PD‐L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance
Author:
Affiliation:
1. Department of Otolaryngology – Head and Neck Surgery University of California San Francisco San Francisco California USA
2. Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA
Funder
National Cancer Institute
National Institute of Dental and Craniofacial Research
Publisher
Wiley
Subject
Otorhinolaryngology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26827
Reference38 articles.
1. Rising incidence of late‐stage head and neck cancer in the United States
2. Epidemiology and Demographics of the Head and Neck Cancer Population
3. New Therapies in Head and Neck Cancer
4. BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC
5. Bromodomain biology and drug discovery
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review);Oncology Reports;2024-04-12
2. Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases;Journal of Pharmacology and Experimental Therapeutics;2024-04-02
3. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma;Journal of Experimental & Clinical Cancer Research;2023-05-05
4. Small-Molecule PROTACs for Cancer Immunotherapy;Molecules;2022-08-25
5. TMEM16A as a potential treatment target for head and neck cancer;Journal of Experimental & Clinical Cancer Research;2022-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3